newsfilter
← Latest News
GlobeNewswire·

Myriad Genetics to Present at 44th Annual J.P. Morgan Healthcare Conference

SALT LAKE CITY, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostic testing and precision medicine, today announced that Sam Raha, president and CEO, will present at